Po‐Nan Wang

2.5k total citations
83 papers, 1.3k citations indexed

About

Po‐Nan Wang is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Po‐Nan Wang has authored 83 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 23 papers in Genetics and 20 papers in Oncology. Recurrent topics in Po‐Nan Wang's work include Acute Myeloid Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (17 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Po‐Nan Wang is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (17 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Po‐Nan Wang collaborates with scholars based in Taiwan, United States and France. Po‐Nan Wang's co-authors include Ming‐Chung Kuo, Jin‐Hou Wu, Lee‐Yung Shih, Po Dunn, Tung‐Liang Lin, Hung Chang, Tzung‐Chih Tang, Chein‐Fuang Huang, Yu‐Shin Hung and Chang‐Liang Lai and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Po‐Nan Wang

81 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Nan Wang Taiwan 20 727 363 309 299 248 83 1.3k
Oumédaly Reman France 20 635 0.9× 327 0.9× 236 0.8× 385 1.3× 362 1.5× 61 1.4k
Francesco Nobile Italy 21 846 1.2× 429 1.2× 516 1.7× 221 0.7× 193 0.8× 74 1.4k
Silvia Park South Korea 21 650 0.9× 299 0.8× 203 0.7× 581 1.9× 260 1.0× 163 1.5k
Matthew D. Seftel Canada 24 741 1.0× 225 0.6× 289 0.9× 524 1.8× 326 1.3× 111 1.6k
Federica Sorà Italy 18 513 0.7× 208 0.6× 227 0.7× 296 1.0× 110 0.4× 95 1.2k
Jason Tay Canada 20 693 1.0× 394 1.1× 321 1.0× 341 1.1× 90 0.4× 108 1.6k
Okke de Weerdt Netherlands 17 627 0.9× 393 1.1× 173 0.6× 250 0.8× 85 0.3× 49 1.1k
G. L. Phillips Canada 20 931 1.3× 265 0.7× 325 1.1× 507 1.7× 283 1.1× 47 1.6k
Aby Abraham India 20 910 1.3× 467 1.3× 256 0.8× 294 1.0× 67 0.3× 175 1.4k
Jyh-Pyng Gau Taiwan 16 1.0k 1.4× 562 1.5× 295 1.0× 415 1.4× 188 0.8× 62 1.7k

Countries citing papers authored by Po‐Nan Wang

Since Specialization
Citations

This map shows the geographic impact of Po‐Nan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Nan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Nan Wang more than expected).

Fields of papers citing papers by Po‐Nan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Nan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Nan Wang. The network helps show where Po‐Nan Wang may publish in the future.

Co-authorship network of co-authors of Po‐Nan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Nan Wang. A scholar is included among the top collaborators of Po‐Nan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Nan Wang. Po‐Nan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Chao‐Wei, Shin‐Cheh Chen, Po‐Nan Wang, et al.. (2024). Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan. Hepatology International. 18(2). 449–460. 2 indexed citations
3.
Chang, Hung, Che‐Wei Ou, Ming‐Chung Kuo, et al.. (2023). Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma. Clinical and Experimental Medicine. 23(7). 3759–3766. 2 indexed citations
5.
Liu, Hsi‐Che, Ming‐Chung Kuo, Kang‐Hsi Wu, et al.. (2023). Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan. British Journal of Cancer. 128(7). 1294–1300. 5 indexed citations
6.
Tsai, Cheng‐Hong, Tzu‐Ting Chen, Jyh‐Pyng Gau, et al.. (2022). Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry. Cancers. 14(4). 1097–1097. 7 indexed citations
8.
Huang, Ying‐Jung, Ming‐Chung Kuo, Tang‐Her Jaing, et al.. (2021). Comparison of Two Quantitative PCR–Based Assays for Detection of Minimal Residual Disease in B-Precursor Acute Lymphoblastic Leukemia Harboring Three Major Fusion Transcripts. Journal of Molecular Diagnostics. 23(10). 1373–1379. 4 indexed citations
9.
Kuo, Ming‐Chung, Chien‐Feng Sun, Jin‐Hou Wu, et al.. (2017). The clinical and prognostic relevance of driver mutations in 203 Taiwanese patients with primary myelofibrosis. Journal of Clinical Pathology. 71(6). 514–521. 3 indexed citations
11.
Chang, Hung, Ming‐Chung Kuo, Tzung‐Chih Tang, et al.. (2017). Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia. Acta Haematologica. 138(1). 10–13. 19 indexed citations
12.
Chuang, Wen‐Yu, Hung Chang, Lee‐Yung Shih, et al.. (2015). CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 467(5). 571–582. 25 indexed citations
13.
Shih, Lee‐Yung, Hung Chang, Po‐Nan Wang, et al.. (2013). Clinical Features of Testicular Lymphoma. Acta Haematologica. 131(3). 187–192. 1 indexed citations
14.
Kuo, Tseng‐tong, et al.. (2012). Coexistent bullous and pustular mycosis fungoides in a patient with staphylococcal sepsis. International Journal of Dermatology. 52(1). 79–83.
15.
Lin, Tung‐Liang, Ming‐Chung Kuo, Lee‐Yung Shih, et al.. (2012). The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Annals of Hematology. 91(9). 1383–1391. 37 indexed citations
16.
Hsieh, Ching‐Lin, Wen‐Jin Cherng, Chun‐Chi Chen, et al.. (2011). Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after coronary stenting. Heart and Vessels. 27(1). 10–19. 11 indexed citations
17.
Dunn, Po, Tseng‐tong Kuo, Lee‐Yung Shih, et al.. (2004). Primary Salivary Gland Lymphoma: A Clinicopathologic Study of 23 Cases in Taiwan. Acta Haematologica. 112(4). 203–208. 38 indexed citations
19.
Yeow, Kee‐Min, Cheng‐Hsu Wang, Jen‐Shi Chen, et al.. (1999). The Groshong Peripheral Inserted Central (PIC) Catheter: Initial Experience with Ultrasound-guided Insertion. 24(2). 61–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026